Related Experiment Video
Updated: Mar 19, 2026

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
A systems biology and proteomics-based approach identifies SRC and VEGFA as biomarkers in risk factor mediated
Alexandar V1, Pradeep G Nayar2, R Murugesan1
1Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Kelambakkam 603 103, Tamil Nadu, India.
Insights
A systems biology approach identified novel molecular signatures and serum biomarkers for coronary heart disease (CHD). These findings link traditional risk factors to CHD pathophysiology, aiding in diagnosis.
Area of Science:
- Cardiovascular Research
- Systems Biology
- Molecular Medicine
Background:
- Coronary heart disease (CHD) is a leading global cause of mortality, exacerbated by risk factors like smoking, hypertension, obesity, and diabetes.
- The precise molecular mechanisms linking these risk factors to CHD remain incompletely understood due to disease complexity and a lack of integrative analysis.
Purpose of the Study:
- To develop a novel systems biology approach to elucidate the molecular mechanisms underlying CHD risk factors.
- To identify potential diagnostic biomarkers for CHD by integrating genetic, protein interaction, and pathway data.
Main Methods:
- Literature mining to identify causative genes for CHD and risk factors.
- Construction and analysis of protein-protein interaction networks to find common molecular signatures.
- Mapping signatures to tissue networks to identify functional modules and candidate biomarkers (SRC, VEGFA, HIF1A).
- Validation of candidate biomarkers (SRC, VEGFA, HIF1A) alongside existing markers (CRP, NOS3, VCAM1) using ELISA in patient and control serum samples.
Main Results:
- A sub-network of 82 proteins and key functional modules (AKT/p13k, MAPK, wnt pathways) were identified.
- SRC, VEGFA, and HIF1A were prioritized as potential diagnostic markers.
- SRC, VEGFA, HIF1A, CRP, and NOS3 showed significant alterations in CHD patients compared to controls.
Conclusions:
- The study highlights the influence of traditional risk factors on CHD pathophysiology through identified molecular pathways.
- Validated serum markers (SRC, VEGFA, HIF1A, CRP, NOS3) show promise for improving CHD diagnosis.
Abstract:
Coronary heart disease (CHD) is the most common cause of death worldwide. The burden of CHD increases with risk factors such as smoking, hypertension, obesity and diabetes. Several studies have demonstrated the association of these classical risk factors with CHD. However, the mechanisms of these associations remain largely unclear due to the complexity of disease pathophysiology and the lack of an integrative approach that fails to provide a definite understanding of molecular linkage. To overcome these problems, we propose a novel systems biology approach that relates causative genes, interactomes and pathways to elucidate the risk factors mediating the molecular mechanisms and biomarkers for feasible diagnosis. The literature was mined to retrieve the causative genes of each risk factor and CHD to construct protein interactomes. The interactomes were examined to identify 298 common molecular signatures. The common signatures were mapped to the tissue network to synthesize a sub-network consisting of 82 proteins. Further, the dissection of the sub-network provides functional modules representing a diverse range of molecular functions, including the AKT/p13k, MAPK and wnt pathways. Also, the prioritization of functional modules identifies SRC, VEGFA and HIF1A as potential candidate markers. Further, we validate these candidates with the existing markers CRP, NOS3 and VCAM1 in the serum of 63 individuals, 33 with CHD and 30 controls, using ELISA. SRC, VEGFA, H1F1A, CRP and NOS3 were significantly altered in patients compared to controls. These results support the utility of these candidate markers for the diagnosis of CHD. Overall, our molecular observations indicate the influence of risk factors in the pathophysiology of CHD and identify serum markers for diagnosis.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Regulation of Angiogenesis and Blood Supply
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures

